Cobra manufactures biopharmaceuticals used by drug developers in pre-clinical and clinical trials. It has facilities at Keele and Oxford. Biopharmaceuticals are medicines where the main ingredient can't be synthesised. They are made from the manipulation of DNA, viruses or proteins. Cobra has historically concentrated on Phase I/II trials but in 2006 it won Phase III business.